Tag: CX
CX 2024 promises “not only the complex, the new, the innovative,...
CX Executive Board members Nicholas Inston (Birmingham, United Kingdom) and Kate Steiner (Stevenage, United Kingdom) discuss some of the highlights of this year’s CX...
CX 2024 controversies programme to draw in global voices to ensure...
This year’s 2024 Chairing Cross (CX) Symposium (23–25 April, London, UK) will feature debates on the success of endovascular arteriovenous fistulas (AVFs) alongside patient...
“EndoAVF 2.0” projects evaluated in CX debate
The advent of endovascular arteriovenous fistula (endoAVF) creation with the development of the Ellipsys (Medtronic) and WavelinQ (BD) systems marks a “major innovation in...
How effective is cost effectiveness for dialysis patients?
Attendees at the 2023 Charing Cross (CX) Symposium (25–27 April, London, UK) renal interventions session were treated to two presentations exploring the issue of...
CX 2023: IN.PACT AV three-year subanalysis trial data show “durable” long-term...
The vascular access masterclass session on Tuesday saw a first-to-podium presentation by Andrew Holden (Auckland City Hospital, Auckland, New Zealand) in which he presented...
CX 2023: Peritoneal dialysis underutilised “across the world” despite advantages
Peritoneal dialysis (PD) has a number of advantages over haemodialysis—yet with a few exceptions, it is underutilised in most countries. So went the argument...
CX returns to in-person format once more in the London spring
Charing Cross (CX) chair Roger Greenhalgh welcomes the vascular community to this year's symposium, due to be held 26–28 April in London, UK, and...